Evrys Bio
Pre-clinicalEvrys Bio is developing safe and effective, first-in-class therapies that can simultaneously treat a broad spectrum of viruses, while preventing drug resistance.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $6.7M
About
Evrys Bio is developing safe and effective, first-in-class therapies that can simultaneously treat a broad spectrum of viruses, while preventing drug resistance.
Small Molecules
Funding History
1Total raised:$6.7M
Seed$6.7MJan 15, 2023